AMA Tasmania warns over mild Hyperbaric Oxygen Therapy

The Australian Medical Association (AMA) Tasmania is concerned northern residents are
being exposed to misinformation surrounding Mild Hyperbaric Oxygen Therapy (HBOT),
which could leave them out of pocket in the long run.

AMA Tasmania President Dr Tim Greenaway said while HBOT in general had increased in
popularity and use worldwide, it was still a very technical process with numerous variables
and consumers needed to consult their doctor before considering it as an option.

“HBOT is the process of enhancing the body’s natural healing process by exposing it to 100
per cent oxygen in a full-body chamber, which requires the delivery of more than two units of
atmosphere absolute (ATA) pressure,” Dr Greenaway said.

“The problem we are faced with is that mild-HBOT uses less than 1.3 ATA, achieving around
a 50 per cent oxygen level, which has yet to be proven as providing any medical benefit, with
three separate Federal Government evidence-based reviews not supporting the treatment.

“It is for this reason that it is not included on the Medicare benefits schedule, resulting in no
payable Medicare benefit.”

Dr Greenaway reminded residents that they should always consult their GP before trying any
new treatment as they will be able to provide the most up-to-date and scientifically proven
treatments.

“People who think mild-HBOT will assist them, should discuss it with their GP first, as in
most cases a proven alternative will aid with the body’s recovery,” he said.

“Should HBOT be required, the state referral centre for Hyperbaric Medicine is in Hobart,
which is a comprehensive medical facility, supported by highly skilled technical, medical and
nursing staff.”
AMA Tasmania President Dr Tim Greenaway